Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittmer

Showing results (391-400 of 600) with videos related to

Pageof 60
Sort By:
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
The Science of the Total Environment|January 15, 2026
Global drivers of variation in blood mercury of seabirds revealed by a meta-analysisJumpei Okado, Bungo Nishizawa, Johannes H Fischer, et al.
Water Research|November 16, 2024
Making Waves: A justice-centred framework for wastewater-based public health surveillanceMohammed Rafi Arefin, Carolyn Prouse, Josie Wittmer, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Pageof 60

Showing results (391-400 of 600) with videos related to

Sort By:
Pageof 60
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
The Science of the Total Environment|January 15, 2026
Global drivers of variation in blood mercury of seabirds revealed by a meta-analysisJumpei Okado, Bungo Nishizawa, Johannes H Fischer, et al.
Water Research|November 16, 2024
Making Waves: A justice-centred framework for wastewater-based public health surveillanceMohammed Rafi Arefin, Carolyn Prouse, Josie Wittmer, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Pageof 60